Hepatitis B in chronic kidney disease: moving toward effective prevention.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18340351.
- Also identified by DOI 10.1038/ki.2008.57.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Control of hepatitis B virus (HBV) infection has been a continuous challenge in the management of patients with advanced kidney disease. HBV infections are still difficult to treat, so the main objective is disease prevention by timely immunization with hepatitis B surface antigen vaccines. In the general population, a simple two- or three-standard-dose vaccination strategy has been proven to be highly successful. In contrast, an intensified and more tailored approach is evolving in patients with advanced renal failure.
Medical subject headings
- Hepatitis B
- Hepatitis B Vaccines
- Kidney Diseases